Literature DB >> 33177063

Eph Receptors in the Immunosuppressive Tumor Microenvironment.

Peter W Janes1, Mary E Vail2, Matthias Ernst3, Andrew M Scott2.   

Abstract

The tumor microenvironment (TME) promotes tumor development via complex intercellular signaling, aiding tumor growth and suppressing immunity. Eph receptors (Eph) and their ephrin ligands control cell interactions during normal development, and reemerge in tumors and the TME, where they are implicated in invasion, metastasis, and angiogenesis. Recent studies also indicate roles for Ephs in suppressing immune responses by controlling tumor interactions with innate and adaptive immune cells within the TME. Accordingly, inhibiting these functions can promote immune response and efficacy of immune checkpoint inhibition. This research highlights Ephs as potential targets to enhance efficacy of immune-based therapies in patients with cancer. ©2020 American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 33177063     DOI: 10.1158/0008-5472.CAN-20-3047

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

Review 1.  The EPH/Ephrin System in Bone and Soft Tissue Sarcomas' Pathogenesis and Therapy: New Advancements and a Literature Review.

Authors:  Argyris C Hadjimichael; Alexandros Pergaris; Angelos Kaspiris; Athanasios F Foukas; Stefania Kokkali; Gerasimos Tsourouflis; Stamatios Theocharis
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

2.  Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma.

Authors:  Chongli Zhang; Yong Cui; Guannan Wang; Wugan Zhao; Haiyu Zhao; Xuejie Huang; Min Zhang; Wencai Li
Journal:  J Healthc Eng       Date:  2021-09-06       Impact factor: 2.682

Review 3.  The EPH/Ephrin System in Colorectal Cancer.

Authors:  Stavros P Papadakos; Leonidas Petrogiannopoulos; Alexandros Pergaris; Stamatios Theocharis
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

4.  EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer.

Authors:  Peng Zheng; XiaoLong Liu; Haiyuan Li; Lei Gao; Yang Yu; Na Wang; Hao Chen
Journal:  Front Genet       Date:  2022-01-19       Impact factor: 4.599

5.  Human fibroblasts facilitate the generation of iPSCs-derived mammary-like organoids.

Authors:  Xueqin Dai; Xinye Wang; Chuanyu Yang; Maobo Huang; Zhongmei Zhou; Ying Qu; Xiaojiang Cui; Rong Liu; Ceshi Chen
Journal:  Stem Cell Res Ther       Date:  2022-07-28       Impact factor: 8.079

6.  Expression characteristic, immune signature, and prognosis value of EFNA family identified by multi-omics integrative analysis in pan-cancer.

Authors:  Zonglin Jiao; Xiao Feng; Yuqing Cui; Lei Wang; Junqing Gan; Yanbin Zhao; Qingwei Meng
Journal:  BMC Cancer       Date:  2022-08-10       Impact factor: 4.638

7.  A comprehensive prognostic and immunological analysis of ephrin family genes in hepatocellular carcinoma.

Authors:  Shenglan Huang; Cairong Dong; Jian Zhang; Shumin Fu; Yaqin Lv; Jianbing Wu
Journal:  Front Mol Biosci       Date:  2022-08-16

Review 8.  Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition.

Authors:  Roger J Daly; Andrew M Scott; Oliver Klein; Matthias Ernst
Journal:  Mol Cancer       Date:  2022-09-29       Impact factor: 41.444

9.  ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.

Authors:  Jiazhou Liu; Yuxian Wei; Yushen Wu; Jie Li; Jiazheng Sun; Guosheng Ren; Hongzhong Li
Journal:  Front Immunol       Date:  2021-04-14       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.